Device Servicing And Remanufacturing: US FDA, Stakeholders Try To Draw Distinction
Executive Summary
US FDA’s device center in concert with third-party servicers and original equipment manufacturers are working toward consensus on how to differentiate medtech "servicing" from "remanufacturing" activities. Progress was made at a recent workshop in laying out ways that better training and more data sharing will help.
You may also be interested in...
Senators Want Answers From FDA Soon On Device Servicing Versus Remanufacturing
US Senators Elizabeth Warren and Bill Cassidy recently sent a letter to FDA acting commissioner Ned Sharpless prodding him to provide them details by 1 November on how the agency plans to regulate medical device servicers that may actually be remanufacturing devices.
New MITA Standard Helps Servicers Of Imaging Devices Develop Quality Systems, Avoid Remanufacturing
The Medical Imaging & Technology Alliance has released a voluntary standard that guides servicers of medical imaging equipment on how to best set up a quality system. NEMA/MITA 2 also aims to keep servicers from crossing the line into remanufacturing – an FDA-regulated activity.
Trade Group Suggests New Guidelines On Imaging Device Servicing, Remanufacturing
A new white paper from the Medical Imaging & Technology Alliance suggests ways US FDA could better distinguish between imaging device servicing and remanufacturing. The agency has previously announced plans to clarify the difference.